ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,213.49
0.51%
Dow Jones
38,675.68
1.18%
Gold vs US Dollar
2,302.57
0.00%
Brent Oil
82.765
0.00%
Bitcoin
64,278.04
2.21%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Selecta Biosciences Inc (SELB)

  7. Selecta Biosciences Inc (SELB) News

Selecta Biosciences (SELB)

Selecta Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SELB
DateTimeSourceHeadlineSymbolCompany
26/04/202414:09Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SELBSelecta Biosciences Inc
26/04/202412:57Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SELBSelecta Biosciences Inc
22/04/202411:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SELBSelecta Biosciences Inc
19/04/202421:49Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SELBSelecta Biosciences Inc
11/04/202402:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SELBSelecta Biosciences Inc
11/04/202402:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SELBSelecta Biosciences Inc
11/04/202402:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SELBSelecta Biosciences Inc
11/04/202402:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SELBSelecta Biosciences Inc
11/04/202402:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SELBSelecta Biosciences Inc
10/04/202421:29Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:SELBSelecta Biosciences Inc
10/04/202421:25Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:SELBSelecta Biosciences Inc
10/04/202421:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SELBSelecta Biosciences Inc
09/04/202412:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SELBSelecta Biosciences Inc
01/04/202421:32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SELBSelecta Biosciences Inc
28/03/202421:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SELBSelecta Biosciences Inc
14/03/202411:55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SELBSelecta Biosciences Inc
07/03/202412:08Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:SELBSelecta Biosciences Inc
07/03/202412:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SELBSelecta Biosciences Inc
05/03/202412:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SELBSelecta Biosciences Inc
14/02/202422:27Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SELBSelecta Biosciences Inc
14/02/202421:42Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SELBSelecta Biosciences Inc
14/02/202417:38Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:SELBSelecta Biosciences Inc
31/01/202421:30Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:SELBSelecta Biosciences Inc
23/01/202421:05Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:SELBSelecta Biosciences Inc
19/01/202421:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SELBSelecta Biosciences Inc
12/01/202421:16Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SELBSelecta Biosciences Inc
08/01/202413:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SELBSelecta Biosciences Inc
08/01/202412:10GlobeNewswire Inc.Cartesian Therapeutics Highlights Progress and 2024 Strategic Priorities Across Innovative Pipeline of mRNA Cell Therapies for AutoimmunityNASDAQ:SELBSelecta Biosciences Inc
08/01/202412:00GlobeNewswire Inc.Cartesian Therapeutics Announces Positive Long-Term Follow-Up Data from Phase 2a Study of Lead mRNA Cell Therapy Candidate Descartes-08 in Patients with Myasthenia GravisNASDAQ:SELBSelecta Biosciences Inc
04/01/202422:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SELBSelecta Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:SELB

Your Recent History

LSE
SCLP
Scancell
LSE
AGL
Angle
LSE
EEE
Empire Metals
LSE
FUM
Futura Medical
LSE
AAU
Ariana Resources
LSE
GFM
Griffin Mining
LSE
PHNX
Phoenix
LSE
SCE
Surface Transforms
LSE
HARL
Harland & Wolff
LSE
YU.
Yu
LSE
AAZ
Anglo Asian Mining
LSE
MIN
Minoan
LSE
JEMA
Jpmorgan Emerging Europe...
LSE
TERN
Tern
LSE
CNR
Condor Gold
LSE
BEN
Bens Creek
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved